The ability to avoid routine needle carrying skyrocketed the value-based price (VBP) of nasal epinephrine to more than 1200% above baseline, according to new modeling data presented at the annual ...

EU grants marketing approval to ALK’s EURneffy 1 mg, a needle-free adrenaline treatment for young children at risk of anaphylaxis: Denmark Thursday, April 2, 2026, 13:00 Hrs [IS ...

Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a global ...

Celltrion said on the 20th that it obtained additional approval from Health Canada for the auto-injector (AI) formulation of the autoimmune disease treatment biosimilar "Steqeyma" (ingredient name ...

Researchers boosted levels of a heart-healing hormone in mice and pigs with a single injection of a new, experimental form of self-amplifying RNA that prolonged hormone synthesis for many weeks. When ...

Embecta, a company that develops diabetes management solutions, is moving into the auto-injection market with its latest planned acquisition. The Becton Dickinson & CO spinoff reported it would ...

Today, ALK announced that children aged 4 and older living with severe allergies across the EU can now access the first and only needle-free adrenaline treatment for anaphylaxis, after the European ...

A new RNA-based therapy aims to address one of cardiology’s most persistent challenges: the heart’s inability to regenerate after injury.

Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company") today announced its wholly-owned subsidiary, Halozyme ...

For developers using AI, “vibe coding” right now comes down to babysitting every action or risking letting the model run unchecked. Anthropic says its latest update to Claude aims to eliminate that ...

South Carolina is preparing this week to execute a man by firing squad, a capital punishment method that hasn’t been used in ...